G1 Therapeutics, Inc. financial data

Symbol
GTHX on Nasdaq
Location
700 Park Offices Drive, Suite 200, Research Triangle Park, NC
State of incorporation
DE
Fiscal year end
December 31
Former names
G-Zero Therapeutics, Inc. (to 4/18/2013)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 322 % -28.4%
Quick Ratio 38.9 % -11%
Debt-to-equity 248 % +20.6%
Return On Equity -137 % +4.38%
Return On Assets -39.3 % +16.1%
Operating Margin -65.1 % +12.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 52.8M shares +1.96%
Common Stock, Shares, Outstanding 52.7M shares +1.91%
Entity Public Float 128M USD -39%
Common Stock, Value, Issued 5K USD +25%
Weighted Average Number of Shares Outstanding, Basic 52.5M shares +1.56%
Weighted Average Number of Shares Outstanding, Diluted 52.5M shares -14%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 58.2M USD -34.7%
Research and Development Expense 29.2M USD -54.1%
Operating Income (Loss) -37.9M USD +43.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -43M USD +42.6%
Income Tax Expense (Benefit) 1.81M USD -39.9%
Net Income (Loss) Attributable to Parent -44.8M USD +42.5%
Earnings Per Share, Basic -0.87 USD/shares +48.2%
Earnings Per Share, Diluted -0.84 USD/shares +50.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 15.1M USD -73%
Marketable Securities, Current 45.7M USD -5.51%
Accounts Receivable, after Allowance for Credit Loss, Current 13.3M USD +1.05%
Inventory, Net 13.4M USD -14.2%
Assets, Current 92.9M USD -33.8%
Property, Plant and Equipment, Net 1.24M USD -28.5%
Operating Lease, Right-of-Use Asset 4.35M USD -20.2%
Assets 98.7M USD -33.3%
Accounts Payable, Current 5.16M USD -10.5%
Employee-related Liabilities, Current 1.97M USD -28.2%
Accrued Liabilities, Current 17.1M USD -30.8%
Liabilities, Current 37.5M USD +10.6%
Operating Lease, Liability, Noncurrent 3.65M USD -27%
Other Liabilities, Noncurrent 41K USD
Liabilities 74.1M USD -18%
Retained Earnings (Accumulated Deficit) -796M USD -5.96%
Stockholders' Equity Attributable to Parent 24.6M USD -57.3%
Liabilities and Equity 98.7M USD -33.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.9M USD +69.4%
Net Cash Provided by (Used in) Financing Activities -8.72M USD -3976%
Net Cash Provided by (Used in) Investing Activities 5.29M USD +81.8%
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 52.7M shares +1.91%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -12.3M USD +53.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.82M USD -27.4%
Deferred Tax Assets, Valuation Allowance 184M USD +5.68%
Deferred Tax Assets, Gross 185M USD +5.45%
Operating Lease, Liability 5.62M USD -16.8%
Depreciation 881K USD +63.8%
Lessee, Operating Lease, Liability, to be Paid 6.53M USD -20%
Operating Lease, Liability, Current 1.28M USD +12.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.73M USD +2.74%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.68M USD +2.75%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 918K USD -35.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.77M USD +2.78%
Deferred Tax Assets, Operating Loss Carryforwards 121M USD +2.32%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.36M USD -23.5%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 120K USD -9.09%
Share-based Payment Arrangement, Expense 11.5M USD -31.7%